Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4579
Abstract: The phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) pathway controls insulin sensitivity and glucose metabolism. Hyperglycemia is one of the most common on‐target adverse effects (AEs) of PI3K/AKT inhibitors. As several PI3K and AKT inhibitors are… read more here.
Keywords: pi3k akt; factors hyperglycemia; management; risk factors ... See more keywords
Risk factors for hyperglycemia in extremely low birth weight infants during the first 14 days.
Sign Up to like & getrecommendations! Published in 2021 at "Pediatrics and neonatology"
DOI: 10.1016/j.pedneo.2021.07.001
Abstract: BACKGROUND There are limited data regarding the risk factors for hyperglycemia in extremely low birth weight infants (ELBWIs). The aim of this observational study was to investigate the incidence of hyperglycemia among ELBWIs during the… read more here.
Keywords: factors hyperglycemia; hyperglycemia extremely; risk; risk factors ... See more keywords